Metastatic bone disease: Pathogenesis and therapeutic options
Bone metastases (BM) are a common complication of cancer, whose management often requires a multidisciplinary approach. Despite the recent therapeutic advances, patients with BM may still experience skeletal-related events and symptomatic skeletal events, with detrimental impact on quality of life a...
Main Authors: | Stella D'Oronzo, Robert Coleman, Janet Brown, Francesco Silvestris |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-04-01
|
Series: | Journal of Bone Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212137418302586 |
Similar Items
-
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer
by: Stella D’Oronzo, et al.
Published: (2020-04-01) -
The role of biomarkers in the management of bone-homing malignancies
by: Stella DâOronzo, et al.
Published: (2017-11-01) -
Natural history of stage II/III breast cancer, bone metastasis and the impact of adjuvant zoledronate on distribution of recurrences
by: Stella D'Oronzo, et al.
Published: (2021-06-01) -
Targeted RNA-seq signature of breast cancer (BC) circulating tumor cells (CTCs) correlates with the onset of bone-only metastases
by: Stella D'oronzo, et al.
Published: (2021-04-01) -
Application of “omics” sciences to the prediction of bone metastases from breast cancer: State of the art
by: Marica Gentile, et al.
Published: (2021-02-01)